Ovarian Cancer: Recurrence After PARP Inhibition
0 Ansichten
administrator
07/08/23
Strategies for approaching patients with ovarian cancer who report a recurrence following treatment with a PARP inhibitor.
Zeig mehr
Facebook Kommentare
Keine Kommentare gefunden